APHA was my #1 Cannabis play going into this year based on the fundamentals and it's held up very well, still my #1 long term pick today (along with tangential Cannabis play IIPR).
That was followed by CGC and ACB with TLRY coming in at #4. Now with my #1 and and #4 plays merging and largely rounding out their strengths and weaknesses, it is an even stronger #1 by a factor of 1, maybe 2 over each CGC and ACB.
Amazingly, TLRY is still dirt cheap sitting at 3% of it's $300 peak a year ago lol.
Price is even UNDER its IPO and BELOW its Value Channel here (magenta). Seems impossible it goes under $2 now so max temporary downside is very constrained.
TLRY now the Best Value Cannabis Stock out there supplanting long reigning champ OGI, which is my #5 play overall but quite underpriced ATM relative to the market.
I'm lookin to scale in most my position before $21 and watching it float up like smoke!
That was followed by CGC and ACB with TLRY coming in at #4. Now with my #1 and and #4 plays merging and largely rounding out their strengths and weaknesses, it is an even stronger #1 by a factor of 1, maybe 2 over each CGC and ACB.
Amazingly, TLRY is still dirt cheap sitting at 3% of it's $300 peak a year ago lol.
Price is even UNDER its IPO and BELOW its Value Channel here (magenta). Seems impossible it goes under $2 now so max temporary downside is very constrained.
TLRY now the Best Value Cannabis Stock out there supplanting long reigning champ OGI, which is my #5 play overall but quite underpriced ATM relative to the market.
I'm lookin to scale in most my position before $21 and watching it float up like smoke!
Data analyst with a passion for best fit lines B)
İlgili yayınlar
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.
Data analyst with a passion for best fit lines B)
İlgili yayınlar
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.